Rituxan Hycela

Genentech, Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 16, 2022
Approval ID: 3e5b7e82-f018-4eaf-ae78-d6145a906b20
Products: 2 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RITUXAN HYCELA safely and effectively. See full prescribing information for RITUXAN HYCELA. RITUXAN HYCELA (rituximab and hyaluronidase human) injection, for subcutaneous useInitial U.S. Approval: 2017

Quick Stats

Total Products2

Labelers2

Label Sections38

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.